116 related articles for article (PubMed ID: 27922504)
1. Genetic Testing of Presymptomatic Individuals at Risk for Progressive Myopathy.
Simmons Z
Continuum (Minneap Minn); 2016 Dec; 22(6, Muscle and Neuromuscular Junction Disorders):2006-2011. PubMed ID: 27922504
[TBL] [Abstract][Full Text] [Related]
2. Ethical Considerations in Neurogenetic Testing.
Su XW; Simmons Z
Semin Neurol; 2018 Oct; 38(5):505-514. PubMed ID: 30321888
[TBL] [Abstract][Full Text] [Related]
3. Ethical issues in the evaluation of adults with suspected genetic neuromuscular disorders.
Su X; Kang PB; Russell JA; Simmons Z
Muscle Nerve; 2016 Dec; 54(6):997-1006. PubMed ID: 27615030
[TBL] [Abstract][Full Text] [Related]
4. Genetic testing and counseling in the diagnosis and management of young-onset dementias.
Goldman JS
Psychiatr Clin North Am; 2015 Jun; 38(2):295-308. PubMed ID: 25998117
[TBL] [Abstract][Full Text] [Related]
5. Ethical issues in neurogenetics.
Uhlmann WR; Roberts JS
Handb Clin Neurol; 2018; 147():23-36. PubMed ID: 29325614
[TBL] [Abstract][Full Text] [Related]
6. Ethical Implications of Direct-to-Consumer Hereditary Cancer Tests.
Kilbride MK; Domchek SM; Bradbury AR
JAMA Oncol; 2018 Oct; 4(10):1327-1328. PubMed ID: 30027223
[No Abstract] [Full Text] [Related]
7. Decision making and experiences of young adults undergoing presymptomatic genetic testing for familial cancer: a longitudinal grounded theory study.
Godino L; Jackson L; Turchetti D; Hennessy C; Skirton H
Eur J Hum Genet; 2018 Jan; 26(1):44-53. PubMed ID: 29162934
[TBL] [Abstract][Full Text] [Related]
8. The highly anxious individual presenting for Huntington disease-predictive genetic testing: the psychiatrist's role in assessment and counseling.
Groves M
Handb Clin Neurol; 2017; 144():99-105. PubMed ID: 28947129
[TBL] [Abstract][Full Text] [Related]
9. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
10. Presymptomatic ALS genetic counseling and testing: Experience and recommendations.
Benatar M; Stanislaw C; Reyes E; Hussain S; Cooley A; Fernandez MC; Dauphin DD; Michon SC; Andersen PM; Wuu J
Neurology; 2016 Jun; 86(24):2295-302. PubMed ID: 27194384
[TBL] [Abstract][Full Text] [Related]
11. Bioethics for clinicians: 14. Ethics and genetics in medicine.
Burgess MM; Laberge CM; Knoppers BM
CMAJ; 1998 May; 158(10):1309-13. PubMed ID: 9614824
[TBL] [Abstract][Full Text] [Related]
12. Genetic counselors: your partners in clinical practice.
Mester JL; Schreiber AH; Moran RT
Cleve Clin J Med; 2012 Aug; 79(8):560-8. PubMed ID: 22854435
[TBL] [Abstract][Full Text] [Related]
13. Legal and ethical issues in genetic testing and counseling for susceptibility to breast, ovarian and colon cancer.
Dickens BM; Pei N; Taylor KM
CMAJ; 1996 Mar; 154(6):813-8. PubMed ID: 8634959
[TBL] [Abstract][Full Text] [Related]
14. The psychological dimension of informed consent: dissonance processes in genetic testing.
Grover S
J Genet Couns; 2003 Oct; 12(5):389-403. PubMed ID: 15043060
[TBL] [Abstract][Full Text] [Related]
15. [The origin of informed consent].
Mallardi V
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
[TBL] [Abstract][Full Text] [Related]
16. The Double Helix: Applying an Ethic of Care to the Duty to Warn Genetic Relatives of Genetic Information.
Weaver M
Bioethics; 2016 Mar; 30(3):181-7. PubMed ID: 26194147
[TBL] [Abstract][Full Text] [Related]
17. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.
J Clin Oncol; 1996 May; 14(5):1730-6; discussion 1737-40. PubMed ID: 8622094
[TBL] [Abstract][Full Text] [Related]
18. Impact of presymptomatic genetic testing on young adults: a systematic review.
Godino L; Turchetti D; Jackson L; Hennessy C; Skirton H
Eur J Hum Genet; 2016 Apr; 24(4):496-503. PubMed ID: 26173961
[TBL] [Abstract][Full Text] [Related]
19. Ethical considerations of genetic presymptomatic testing for Huntington's disease.
Coustasse A; Pekar A; Sikula A; Lurie S
J Hosp Mark Public Relations; 2009; 19(2):129-41. PubMed ID: 19827323
[TBL] [Abstract][Full Text] [Related]
20. Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.
Roberts JS; Uhlmann WR
Prog Neurobiol; 2013 Nov; 110():89-101. PubMed ID: 23583530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
